Evidence map›Paper›PMID 28973897›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2017

Mapping allele with resolved carrier status of Robertsonian and reciprocal translocation in human preimplantation embryos.

Jiawei Xu, Zhen Zhang, Wenbin Niu, Qingling Yang, Guidong Yao, Senlin Shi, Haixia Jin, Wenyan Song, Lei Chen, Xiangyang Zhang and 15 more

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 1 pooled it
6.5field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 1 synthesis or guideline pooled it, 63 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors at 4 institutions in 2 countries.

Jiawei XuCenter for Reproductive Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, 450052, China.
Zhen ZhangYikon Genomics Company, Ltd., Shanghai 201499, China.
Wenbin NiuCenter for Reproductive Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, 450052, China.
Qingling YangCenter for Reproductive Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, 450052, China.ORCID 0000-0002-9187-7961
Guidong YaoCenter for Reproductive Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, 450052, China.
Senlin ShiCenter for Reproductive Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, 450052, China.
Haixia JinCenter for Reproductive Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, 450052, China.
Wenyan SongCenter for Reproductive Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, 450052, China.
Lei ChenCenter for Reproductive Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, 450052, China.
Xiangyang ZhangCenter for Reproductive Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, 450052, China.
Yihong GuoCenter for Reproductive Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, 450052, China.
Yingchun SuCenter for Reproductive Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, 450052, China.
Linli HuCenter for Reproductive Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, 450052, China.
Jun ZhaiCenter for Reproductive Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, 450052, China.
Yile ZhangCenter for Reproductive Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, 450052, China.
Fangli DongCenter for Reproductive Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, 450052, China.
Yumei GaoYikon Genomics Company, Ltd., Shanghai 201499, China.
Wenhui LiYikon Genomics Company, Ltd., Shanghai 201499, China.
Shiping BoYikon Genomics Company, Ltd., Shanghai 201499, China.
Mintao HuYikon Genomics Company, Ltd., Shanghai 201499, China.
Jun RenYikon Genomics Company, Ltd., Shanghai 201499, China.
Lei HuangDepartment of Chemistry and Chemical Biology, Harvard University, Cambridge, Massachusetts 02138.
Sijia LuYikon Genomics Company, Ltd., Shanghai 201499, China; syp2008@vip.sina.com xie@chemistry.harvard.edu lusijia@yikongenomics.com.
X Sunney XieDepartment of Chemistry and Chemical Biology, Harvard University, Cambridge, Massachusetts 02138; syp2008@vip.sina.com xie@chemistry.harvard.edu lusijia@yikongenomics.com.
Yingpu SunCenter for Reproductive Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, 450052, China; syp2008@vip.sina.com xie@chemistry.harvard.edu lusijia@yikongenomics.com.
First Affiliated Hospital of Zhengzhou University · CNSinotech Genomics (China) · CNBrigham and Women's Hospital · USHarvard University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Reciprocal translocations (RecT) and Robertsonian translocations (RobT) are among the most common chromosomal abnormalities that cause infertility and birth defects. Preimplantation genetic testing for aneuploidy using comprehensive chromosome screening for in vitro fertilization enables embryo selection with balanced chromosomal ploidy; however, it is normally unable to determine whether an embryo is a translocation carrier. Here we report a method named "Mapping Allele with Resolved Carrier Status" (MaReCs), which enables chromosomal ploidy screening and resolution of the translocation carrier status of the same embryo. We performed MaReCs on 108 embryos, of which 96 were from 13 RecT carriers and 12 were from three RobT carriers. Thirteen of the sixteen patients had at least one diploid embryo. We have confirmed the accuracy of our carrier status determination in amniotic fluid karyotyping of seven cases as well as in the live birth we have thus far. Therefore, MaReCs accurately enables the selection of translocation-free embryos from patients carrying chromosomal translocations. We expect MaReCs will help reduce the propagation of RecT/RobT in the human population.

Indexed as

BlastocystFertilization in VitroPreimplantation DiagnosisTranslocation, GeneticAllelesChromosome AberrationsEmbryo TransferFemaleGenetic Carrier ScreeningHumansInfertilityLive BirthMalePregnancyPregnancy Outcomechromosomal abnormalityIVFMALBACPGDtranslocation

Identifiers

PMID28973897
PMCPMC5642733
OpenAlexW2761116170

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.